Stocks
Sunshine Biopharma, Inc.

Sunshine Biopharma, Inc.SBFM

NASDAQHealthcareBiotechnology$1.06-0.90%

Price as of · delayed, not real-time

Focused on the development of novel cancer therapies, this biopharmaceutical company specializes in small molecule drug candidates targeting hard-to-treat cancers. With a market cap of $5.4 million, it is considered a micro-cap stock, attracting investors interested in high-risk, high-reward opportunities in the oncology space.

Market Cap: $5.4M52W Range: $1.01-$24.30

Congressional Interest in Sunshine Biopharma, Inc. (SBFM)

1 member of Congress has disclosed 1 trade in Sunshine Biopharma, Inc. (SBFM), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0

Who in Congress Is Trading SBFM?

2022-06-30$1K-$15K
Stock